Early Cystic Fibrosis Lung Disease Studies in Humans, NHLBI (R01)
ArchivedNational Institutes of Health
Description
This FOA, issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, invites Research Project Grant (R01) applications that propose to investigate the early origins of cystic fibrosis (CF) lung disease and the mechanisms involved in development and progression of pulmonary abnormalities in young children with this condition. Studies may explore novel strategies for detecting early lung disease in infants and young children with CF, including minimally invasive biomarkers and/or imaging approaches, and utilize these methods to elucidate the molecular and cellular mechanisms of early lung disease onset and progression. The ultimate goal is development of novel approaches for diagnosis, prevention, and treatment of early CF lung disease.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedAug 19, 2011
- ClosesJan 11, 2012
- Award ceiling$400,000
- Program funding$3,000,000
- CFDA93.838
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro